The cis-4-amino-l-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues

Journal of Medicinal Chemistry

Volumn 55, Issue 7, 2012, Pages 3027-3035

  Mollica, Adriano ^a   Pinnen, Francesco ^a   Stefanucci, Azzurra ^a   Feliciani, Federica ^a   Campestre, Cristina ^a   Mannina, Luisa ^b,c   Sobolev, Anatoly P ^c   Lucente, Gino ^b   Davis, Peg ^d   Lai, Josephine ^d   Ma, Shou Wu ^d   Porreca, Frank ^d   Hruby, Victor J ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS 4 AMINO PROLINE; DELTA OPIATE RECEPTOR; ENDOMORPHIN 2; KAPPA OPIATE RECEPTOR; MOLECULAR SCAFFOLD; MU OPIATE RECEPTOR; PROLINE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; FEMALE; IC 50; LIGAND BINDING; MALE; MOUSE; NONHUMAN; VAS DEFERENS;

EID: 84859804704     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201402v     Document Type: Article

References (46)

1. Zadina, J. E.; Hackler, L.; Ge, L. J.; Kastin, A. J. A potent and selective endogenous agonist for the μ-opiate receptor Nature 1997, 386, 499-502
2. Torino, D.; Mollica, A.; Pinnen, F.; Lucente, G.; Feliciani, F.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue Bioorg. Med. Chem. Lett. 2009, 19, 4115-4118
3. Torino, D.; Mollica, A.; Pinnen, F.; Feliciani, F.; Lucente, G.; Fabrizi, G.; Portalone, G.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-α,β-didehydrophenylalanine (Î"Phe) residues J. Med. Chem. 2010, 53, 4550-4554
4. Giordano, C.; Sansone, A.; Masi, A.; Lucente, G.; Punzi, P.; Mollica, A.; Pinnen, F.; Feliciani, F.; Cacciatore, I.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, J. V. Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 Eur. J. Med. Chem. 2010, 45, 4594-4600
5. Meisenberg, G.; Simmons, W. H. Minireview. Peptides and the blood-brain barrier Life Sci. 1983, 32, 2611-2623
6. Begley, D. J. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system J. Pharm. Pharmacol. 1996, 48, 136-146
7. Shane, R.; Wilk, S.; Bodnar, R. J. Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV Brain Res. 1999, 815, 278-286
8. Mentlein, R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides Regul. Pept. 1999, 85, 9-24
9. Tomboly, C.; Peter, A.; Toth, G. In vitro quantitative study of the degradation of endomorphins Peptides 2002, 23, 1573-1580
10. Schiller, P. W.; Weltrowska, G.; Schmidt, R.; Nguyen, T. M.-D.; Berezowska, I.; Lemieux, C.; Chung, N. N.; Carpenter, K. A.; Wilkes, B. C. Structural and pharmacological aspects of peptidomimetics. In Drug Discovery Strategies and Methods; Makriyannis, A.; Biegel, D., Eds.; Marcel Dekker, Inc.: New York, 2004; pp 147-173.
11. Schiller, P. W. Development of opioid peptide analogs as pharmacologic tools and as potential drugs: Current status and future directions. NIDA Research Monographs (Emerging Technologies and New Directions in Drug Abuse Research, Vol. 112), 1991, pp 180-197.
12. Schiller, P. W. Development of receptor-selective opioid peptide analogs as pharmacologic tools and as potential drugs Handb. Exp. Pharmacol. 1993, 104/1 (opioids I) 681-710
13. Hruby, V. J.; Agnes, R. S. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors Biopolymers 1999, 51, 391-410
14. Hruby, V. J.; Balse, P. M. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads Curr. Med. Chem. 2000, 7, 945-970
15. 3,3-amino acids at the central position Amino Acids 2006, 30, 453-459
16. ...S interactions J. Pept. Sci. 2005, 11, 104-112
17. Pagani Zecchini, G.; Nalli, M.; Mollica, A.; Lucente, G.; Paglialunga Paradisi, M.; Spisani, S. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs J. Pept. Res. 2002, 59, 283-291
18. Gao, Y.; Liu, X.; Wei, J.; Zhu, B.; Chen, Q.; Wang, R. Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2 Bioorg. Med. Chem. Lett. 2005, 15, 1847-1850
19. Mollica, A.; Feliciani, F.; Stefanucci, A.; Cacciatore, I.; Cornacchia, C.; Torino, D.; Pinnen, F. N-(tert)-butyloxycarbonyl-β,β-cyclopentyl- cysteine (acetamidomethyl)-methyl ester for synthesis of novel peptidomimetic derivatives Protein Pept. Lett. 2010, 17, 925-929
20. Mollica, A.; Stefanucci, A.; Feliciani, F.; Lucente, G.; Pinnen, F. Synthesis of (S)-5,6-dibromo-tryptophan derivatives as building blocks for peptide chemistry Tetrahedron Lett. 2011, 52, 2583-2585
21. 5]Enkephalin. A Highly Potent, Delta Opioid Receptor Selective Compound: Comparisons with Proposed Solution Conformations J. Am. Chem. Soc. 1994, 116, 7523-7531
22. Eguchi, M.; Shen, R. W.; Shea, J. P.; Lee, M. S.; Kahn, M. Design, synthesis, and evaluation of opioid analogues with nonpeptidic β-turn scaffold:enkephalin and endomorphin mimetics J. Med. Chem. 2002, 45, 1395-1398
23. Smith, P. E.; Dang, L. X.; Pettitt, B. M. Simulation of the structure and dynamics of the bis(penicillamine) enkephalin zwitterion J. Am. Chem. Soc. 1991, 113, 67-73
24. Smith, G. D.; Griffin, J. F. Conformation of [Leu-5]-enkephalin from X-ray diffraction: features important for recognition at opiate receptor Science 1978, 199, 1214-1216
25. Picone, D.; D'Ursi, A.; Motta, A.; Tancredi, T.; Temessi, P. A. Conformational preferences of [Leu-5]enkephalin in biomimetic media. Investigation by proton Eur. J. Biochem. 1990, 192, 433-439
26. 5]enkephalin J. Am. Chem. Soc. 1990, 112, 822-829
27. Burden, J. E.; Davis, P.; Porreca, F.; Spatola, A. F. Synthesis and biological activities of YkFA analogues: effects of position 4 substitutions and altered ring size on in vitro opioid activity Bioorg. Med. Chem. Lett. 2002, 12, 213-216
28. Sasaki, J.; Matsumura, Y. New Cyclic Peptide. JP 10330398, Tokyo 1998.
29. Mollica, A.; Davis, P.; Ma, S.-W.; Porreca, F.; Lai, J.; Hruby, V. J. Synthesis and biological activity of the first cyclic biphalin analogues Bioorg. Med. Chem. Lett. 2006, 16, 367-372
30. Mollica, A.; Guardiani, G.; Davis, P; Ma, S.-W.; Porreca, F.; Lai, J.; Mannina, L.; Sobolev, A. P.; Hruby, V. J. Synthesis of stable and potent δ/μ opioid peptides: Analogues of H-Tyr- c [ d -Cys-Gly-Phe- d -Cys]-OH by ring-closing-metathesis J. Med. Chem. 2007, 50, 3138-3142
31. Cardillo, G.; Gentilucci, L.; Tolomelli, A.; Spinosa, R.; Calienni, M.; Quasem, A. R.; Spampinato, S. Synthesis and Evaluation of the Affinity toward μ-Opioid Receptors of Atypical, Lipophilic Ligands Based on the Sequence c [Tyr-Pro-Trp-Phe-Gly] J. Med. Chem. 2004, 47, 5198-5203
32. Janecka, A.; Fichna, J.; Kruszynski, R.; Sasaki, Y.; Ambo, A.; Costentin, J.; do-Rego, J. C. Synthesys and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs Biochem. Pharmacol. 2005, 71, 188-195
33. Perlikowska, R.; do-Rego, J. C.; Cravezic, A.; Fichna, J.; Wyrebska, A.; Toth, G.; Janecka, A. Synthesis and biological evaluation of cyclic endomorphin-2 analogs Peptides 2010, 31, 339-345
34. Paglialunga Paradisi, M.; Mollica, A.; Cacciatore, I.; Di Stefano, A.; Pinnen, F.; Caccuri, A. M.; Ricci, G.; Duprè, S.; Spirito, A.; Lucente, G. Proline-Glutamate chimeras in isopeptides. Synthesis and biological evaluation of conformationally restricted glutathione analogues Bioorg. Med. Chem. 2003, 11, 1677-1683
35. Torino, D.; Mollica, A.; Feliciani, F.; Spisani, S.; Lucente, G. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity Bioog. Med. Chem. 2009, 17, 251-259
36. Mollica, A.; Paglialunga Paradisi, M.; Varani, K.; Spisani, S.; Lucente, G. Chemotactic peptides: fMLF-Ome analogues incorporating proline-methionine chimeras as N-terminal residue Bioog. Med. Chem. 2006, 14, 2253-2265
37. Davies, J. S. The cyclization of peptides and depsipeptides J. Peptide Sci. 2003, 9, 471-501
38. Rothe, M.; LohmuIller, M.; Fischer, W.; Taiber, W.; Breuksch, U. Multiple cyclo-oligomerisations on polymeric supports. In Solid Phase Synthesis; Epton, R., Ed.; SPCC: Birmingham, 1990, pp 551-558.
39. Ruckle, T.; De Lavallaz, P.; Keller, M.; Dumy, P.; Mutter, M. Pseudo-prolines in cyclic peptides: conformational stabilization of cyclo[Pro-Thr(Ï̂Me,MePro)-Pro] Tetrahedron 1999, 55, 11281-11288
40. 3-HGlu] in aqueous solution. A new class of enterobactin-type C3-symmetrical ligands? Helv. Chim. Acta 1999, 82, 957-962
41. Gademann, K.; Seebach, D. Synthesis of cyclo-β-tripeptides and their biological in vitro evaluation as antiproliferatives against the growth of human cancer cell lines Helv. Chim. Acta 2001, 84, 2924-2937
42. Song, Y. F.; Zhen, H. M. Synthesis and investigation of the reactive oxygen species of a novel cyclic peptide-2,6-dimethoxyhydroquinone-3- mercaptoacetic acid conjugate Chin. Chem. Lett. 2001, 12, 1075-1078
43. Wang, Z.; Gardell, L. R.; Ossipov, M. H.; Vanderah, T. W.; Brennan, B. B.; Hochgeschwender, U.; Hruby, V. J.; Malan, T. P., Jr.; Lai, J.; Porreca, F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain J. Neurosci. 2001, 21, 1779-1786
44. Mollica, A.; Pinnen, F.; Feliciani, F.; Stefanucci, A.; Lucente, G.; Davis, P.; Porreca, F.; Ma, S.-W.; Lai, J.; Hruby, V. J. New Potent biphalin analogues containing p-fluoro-L-phenylalanine at the 4,4a positions and non-hydrazine linkers Amino Acids 2011, 40, 1503-1511
45. Lai, J.; Ma, S.-W.; Zhu, R.-H.; Rothman, R. B.; Lentes, K. U.; Porreca, F. Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1 b subtype NeuroReport 1994, 5, 2161-2164
46. Meng, F.; Xie, G. X.; Thompson, R. C.; Mansour, A.; Goldstein, A.; Watson, S. J.; Akil, H. Cloning and pharmacological characterization of a rat k opioid receptor Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9954-9958